Search Results - "Grootenhuis, Peter D. J"
-
1
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Published in Proceedings of the National Academy of Sciences - PNAS (15-11-2011)“…Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene that impair the function of CFTR, an epithelial chloride…”
Get full text
Journal Article -
2
Discovery of N‑(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator
Published in Journal of medicinal chemistry (11-12-2014)“…Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation…”
Get full text
Journal Article -
3
A Computational Ensemble Pharmacophore Model for Identifying Substrates of P-Glycoprotein
Published in Journal of medicinal chemistry (25-04-2002)“…P-glycoprotein (P-gp) functions as a drug efflux pump, mediating multidrug resistance and limiting the efficacy of many drugs. Clearly, identification of…”
Get full text
Journal Article -
4
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Published in Proceedings of the National Academy of Sciences - PNAS (03-11-2009)“…Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), a protein kinase A…”
Get full text
Journal Article -
5
Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations
Published in Proteins, structure, function, and bioinformatics (01-03-2016)“…ABSTRACT Cytochrome P450 BM3 (CYP102A1) mutant M11 is able to metabolize a wide range of drugs and drug‐like compounds. Among these, M11 was recently found to…”
Get full text
Journal Article -
6
Efficient Screening of Cytochrome P450 BM3 Mutants for Their Metabolic Activity and Diversity toward a Wide Set of Drug-Like Molecules in Chemical Space
Published in Drug metabolism and disposition (01-09-2011)“…In the present study, the diversity of a library of drug-metabolizing bacterial cytochrome P450 (P450) BM3 mutants was evaluated by a liquid…”
Get full text
Journal Article -
7
Water-Soluble Molecular Capsules: Self-Assembly and Binding Properties
Published in Chemistry : a European journal (01-01-2005)“…The self‐assembly and characterization of water‐soluble calix[4]arene‐based molecular capsules (1⋅2) is reported. The assemblies are the result of ionic…”
Get full text
Journal Article -
8
Performance of 3D-Database Molecular Docking Studies into Homology Models
Published in Journal of medicinal chemistry (29-01-2004)“…The performance of docking studies into protein active sites constructed by homology model building was investigated using CDK2 and factor VIIa screening data…”
Get full text
Journal Article -
9
Unique Overlap in the Prerequisites for Thrombin Inhibition and Oral Bioavailability Resulting in Potent Oral Antithrombotics
Published in Journal of medicinal chemistry (26-09-2002)“…Despite intense research over the last 10 years, aided by the availability of X-ray structures of enzyme−inhibitor complexes, only very few truly orally active…”
Get full text
Journal Article -
10
Informative Library Design as an Efficient Strategy to Identify and Optimize Leads: Application to Cyclin-Dependent Kinase 2 Antagonists
Published in Journal of medicinal chemistry (25-09-2003)“…The application of an informative, iterative library design strategy is presented for lead identification and optimization. The computational algorithm…”
Get full text
Journal Article -
11
A Rapid Computational Method for Lead Evolution: Description and Application to α1-Adrenergic Antagonists
Published in Journal of medicinal chemistry (13-07-2000)“…The high failure rate of drugs in the development phase requires a strategy to reduce risks by generating lead candidates from different chemical classes. We…”
Get full text
Journal Article -
12
Evaluation of a Novel Shape-Based Computational Filter for Lead Evolution: Application to Thrombin Inhibitors
Published in Journal of medicinal chemistry (06-06-2002)“…A novel shape−feature-based computational method is described and used to rapidly filter compound libraries. The computational model, built using…”
Get full text
Journal Article -
13
N-Phenylphenylglycines as Novel Corticotropin Releasing Factor Receptor Antagonists
Published in Journal of medicinal chemistry (06-05-2004)“…Screening of a computationally designed synthetic library led to the discovery of the N-phenylphenylglycines (NPPGs) as a novel class of human corticotropin…”
Get full text
Journal Article -
14
Comparing Performance of Computational Tools for Combinatorial Library Design
Published in Journal of medicinal chemistry (20-11-2003)“…In using computational tools for library design it is necessary to understand the performance and limitations of available methods. This letter reports…”
Get full text
Journal Article -
15
Arylamidrazones as Novel Corticotropin Releasing Factor Receptor Antagonists
Published in Journal of medicinal chemistry (23-05-2002)“…The arylamidrazones have been found to be potent corticotropin releasing factor (CRF) receptor antagonists structurally distinct from previously reported CRF1…”
Get full text
Journal Article -
16
Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs
Published in Pharmaceutical research (01-10-1999)“…To study oral absorption and brain penetration as a function of polar molecular surface area. Measured brain penetration data of 45 drug molecules were…”
Get full text
Journal Article -
17
Pathways for Conformational Interconversion of Calix[4]arenes
Published in Journal of the American Chemical Society (01-02-1995)Get full text
Journal Article -
18
High throughput P450 inhibition screens in early drug discovery
Published in Drug discovery today (01-11-2005)“…HT CYP450 inhibition data - are they useful, and if so, how to get the best use out of them? This review of high throughput (HT) P450 inhibition technologies…”
Get full text
Journal Article -
19
-
20
Constructing a molecular model of the interaction between antithrombin III and a potent heparin analog
Published in Journal of the American Chemical Society (01-03-1991)Get full text
Journal Article